Literature DB >> 10363515

[Causes of visual field defects after vitrectomy].

H Takenaka1, T Maeno, T Mano, H Mitsuda.   

Abstract

PURPOSE: An inferotemporal visual field defect sometimes occurs following vitreous surgery for idiopathic macular hole. There is a possibility that this visual field defect is due to damage to the superonasal retina by fluid or air irrigation through an inferonasal infusion port. We tested this hypothesis by placing the infusion port in the inferonasal sector during vitreous surgery. CASES AND
METHOD: We performed vitreous surgery on 31 eyes with idiopathic macular hole. The infusion port was placed in the inferonasal sector. The vitreous cavity was replanced either by 20% SF6 or 12% C3F8. We did not abrade the retinal pigment epithelium within the hole. The visual field was assessed before and 1 month after surgery using a Goldmann perimeter.
FINDINGS: Three eyes developed a wedge-shaped visual field defect in the inferonasal sector. No visual field defect developed in the other 28 eyes.
CONCLUSION: The findings show that visual field defect following surgery for idiopathic macular hole is dependent upon the site of the infusion port. We presume that the visual field defect is consequent to retinal damage caused by the flow of air or fluid during surgery.

Entities:  

Mesh:

Year:  1999        PMID: 10363515

Source DB:  PubMed          Journal:  Nippon Ganka Gakkai Zasshi        ISSN: 0029-0203


  3 in total

1.  Idiopathic Acquired Temporal Wedge Visual Field Defects.

Authors:  Michael J Gilhooley; Clare L Fraser; Sui Wong; Simon J Hickman; Gordon T Plant
Journal:  Neuroophthalmology       Date:  2016-06-24

2.  Nonarteritic anterior ischemic optic neuropathy and 'visual field defects' following vitrectomy: could they be related?

Authors:  Mehran Taban; Hilel Lewis; Michael S Lee
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-10-06       Impact factor: 3.117

Review 3.  Heavy silicone oil and intraocular inflammation.

Authors:  Francesco Morescalchi; Ciro Costagliola; Sarah Duse; Elena Gambicorti; Barbara Parolini; Barbara Arcidiacono; Mario R Romano; Francesco Semeraro
Journal:  Biomed Res Int       Date:  2014-07-08       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.